Joseph Geraci, CSO/CTO and co-Founder of NetraMark, shared a post on LinkedIn:
“Happy week my friends! Today we announced a major milestone for NetraMark. After a year of preparation we presented our technology, NetraAI, to the FDA through a CPIM meeting. Their comments were favourable and they even provided us with a regulatory pathway to continue to expose our tech to them for validation.
We are excited to welcome this new chapter as we deepen our relationship with the FDA and continue to improve clinical trial success for pharmaceutical sponsors through our truly “novel” tech. A huge thanks to my whole team at NetraMark including Luca Pani for his guidance. It was hard work but this emerging alignment is worth it.”
More posts featuring FDA on OncoDaily